Comparison of modes of prothrombin time reporting in patients with advanced liver disease associated with viral hepatitis

Journal of Thrombosis and Thrombolysis

Volumn 29, Issue 1, 2010, Pages 81-86

  Wei, Yuxiang ^a   Zheng, Dehua ^a   Xiao, Li ^a   Shi, Bingyi ^a  

^a GENERAL HOSPITAL OF PEOPLE'S LIBERATION ARMY   (China)

Author keywords

Liver disease; Prothrombin time; Standardization; Viral hepatitis

Indexed keywords

ANTICOAGULANT AGENT; PROTHROMBIN; REAGENT; THROMBOPLASTIN; WARFARIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL NORMALIZED RATIO; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTHROMBIN TIME; STANDARDIZATION; VIRUS HEPATITIS;

ADULT; AGED; FEMALE; HEPATITIS, VIRAL, HUMAN; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTHROMBIN TIME; THROMBOPLASTIN;

EID: 77949912932     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-009-0330-6     Document Type: Article

References (22)

1. L Amitrano MA Guardascione V Brancaccio A Balzano 2002 Coagulation disorders in liver disease Semin Liver Dis 22 83 96 10.1055/s-2002-23205 10.1055/s-2002-23205 1:CAS:528:DC%2BD38XislCgtbY%3D 11928081
2. M Peck-Radosavljevic 2007 Review article: coagulation disorders in chronic liver disease Aliment Pharmacol Ther 26 21 28 1:CAS:528: DC%2BD2sXhsVyjt7fK 17958516
3. JF Trotter 2006 Coagulation abnormalities in patients who have liver disease Clin Liver Dis 10 665 678 10.1016/j.cld.2006.08.006 10.1016/j.cld.2006. 08.006 17162234
4. TB Stanley DY Jin PJ Lin DW Stafford 1999 The propeptides of the vitamin K-dependent proteins possess different affinities for the vitamin K-dependent carboxylase J Biol Chem 274 16940 16944 10.1074/jbc.274.24.16940 10.1074/jbc.274.24.16940 1:CAS:528:DyaK1MXjvVGktL4%3D 10358041 (Pubitemid 29275147)
5. B Furie BC Furie 1990 Molecular basis of vitamin K-dependent gamma-carboxylation Blood 75 1753 1762 1:CAS:528:DyaK3MXhs1Whsb8%3D 2184900
6. S Sallah W Bobzien 1999 Bleeding problems in patients with liver disease. Ways to manage the many hepatic effects on coagulation Postgrad Med 106 187 190 10.3810/pgm.1999.10.1.720 1:STN:280:DC%2BD3c%2FgtlOisw%3D%3D 10533518 193-5
7. JA Paramo E Rocha 1993 Hemostasis in advanced liver disease Semin Thromb Hemost 19 184 190 10.1055/s-2007-994024 10.1055/s-2007-994024 1:STN:280:DyaK3szmvFGqtw%3D%3D 8362247
8. M Samada Suarez JC Hernández Perera L Ramos Robaina, et al. 2008 Factors that predict survival in patients with cirrhosis considered for liver transplantation Transplant Proc 40 2965 2967 10.1016/j.transproceed.2008.08.110 10.1016/j.transproceed.2008.08.110 1:STN:280:DC%2BD1cjktlKjuw%3D%3D 19010161
9. GS Cooper P Bellamy NV Dawson, et al. 1997 A prognostic model for patients with end-stage liver disease Gastroenterology 113 1278 1288 10.1053/gast.1997.v113.pm9322523 10.1053/gast.1997.v113.pm9322523 1:STN:280:DyaK2svmtlyhsA%3D%3D 9322523 (Pubitemid 27418982)
10. PS Kamath RH Wiesner M Malinchoc, et al. 2001 A model to predict survival in patients with end-stage liver disease Hepatology 33 464 470 10.1053/jhep.2001.22172 10.1053/jhep.2001.22172 1:STN:280:DC%2BD3M7kvVOqug%3D%3D 11172350 (Pubitemid 32119037)
11. RL Carithers Jr HF Herlong AM Diehl, et al. 1989 Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial Ann Intern Med 110 685 690 2648927
12. SJ Munoz 1991 Prothrombin time in fulminant hepatic failure Gastroenterology 100 1480 1481 1:STN:280:DyaK3M7pt1Gmsw%3D%3D 2013397
13. International Committee for Standardization in Haematology 1985 International Committee on Thrombosis and Haemostasis: ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control Thromb Haemost 53 155 156
14. A Piekarska J Zboinska W Szymczak J Kuydowicz 2008 Independent prognostic factors in patients with liver cirrhosis Hepatogastroenterology 55 1034 1040 18705324
15. O Cuomo A Perrella G Arenga 2008 Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system? Transplant Proc 40 1906 1909 10.1016/j.transproceed.2008.05.072 10.1016/j.transproceed.2008.05.072 1:STN:280:DC%2BD1cvpsVKhtg%3D%3D 18675085
16. JW Fang GL Bird T Nakamura GL Davis JY Lau 1994 Hepatocyte proliferation as an indicator of outcome in acute alcoholic hepatitis Lancet 343 820 823 10.1016/S0140-6736(94)92025-7 10.1016/S0140-6736(94)92025-7 1:STN:280: DyaK2c7oslClsA%3D%3D 7908077 (Pubitemid 24147511)
17. LM Forman MR Lucey 2001 Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease Hepatology 33 473 475 10.1053/jhep.2001.22481 10.1053/jhep.2001.22481 1:STN:280:DC%2BD3M7kvVyjsg%3D%3D 11172352 (Pubitemid 32119039)
18. AM van den Besselaar 1990 Recommended method for reporting therapeutic control of oral anticoagulant therapy. Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis Thromb Haemost 63 316 317 2363132
19. A Robert O Chazouilleres 1996 Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio? Hepatology 24 1392 1394 10.1002/hep.510240613 10.1002/hep.510240613 1:STN:280: DyaK2s%2Fpt1OntQ%3D%3D 8938167
20. MJ Kovacs A Wong K MacKinnon K Weir M Keeney E Boyle M Cruickshank 1994 Assessment of the validity of the INR system for patients with liver impairment Thromb Haemost 71 727 730 1:STN:280:DyaK2M%2FmsVKmtg%3D%3D 7605424
21. KW Denson SV Reed ME Haddon 1995 Validity of the INR system for patients with liver impairment Thromb Haemost 73 162 1:CAS:528:DyaK2MXjtFSrsr0%3D 7740488
22. R Arjal JF Trotter 2009 International normalized ratio of prothrombin time in the model for end-stage liver disease score: an unreliable measure Clin Liver Dis 13 67 71 10.1016/j.cld.2008.09.009 10.1016/j.cld.2008.09.009 19150311